SARS-CoV-2 IgM/IgG mgbochi

Foto egosipụtara SARS-CoV-2 IgM/IgG Antibody

Nkọwa dị mkpirikpi:

Ezubere ngwa a maka nchọpụta in vitro qualitative antibody nke SARS-CoV-2 IgG n'ụdị mmadụ nke serum/plasma, ọbara venous na ọbara mkpịsị aka, gụnyere SARS-CoV-2 IgG mgbochi n'ime ndị butere ọrịa na ọgwụ mgbochi.

Zitere anyị email

Nkọwa ngwaahịa

Mkpado ngwaahịa

Aha ngwaahịa

HWTS-RT090-SARS-CoV-2 IgM/IgG Ngwa nchọpụta ihe mgbochi (usoro ọla edo colloidal)

Asambodo

Epidemiology

Ọrịa Coronavirus 2019 (COVID-19), bụ oyi baa n'ihi ọrịa nwere coronavirus akwụkwọ akụkọ aha ya bụ Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2).SARS-CoV-2 bụ coronavirus ọhụrụ na ụdị β na mmadụ na-enwekarị ike ibute SARS-CoV-2.Isi mmalite nke ọrịa bụ ndị ọrịa COVID-19 enwetara na onye na-ebu asymptomatic nke SARS-CoV-2.Dabere na nyocha ọrịa ọrịa ugbu a, oge nnabata bụ ụbọchị 1-14, ọkachasị ụbọchị 3-7.Isi ihe na-egosipụta bụ ahụ ọkụ, ụkwara akọrọ, na ike ọgwụgwụ.Ọnụ ọgụgụ dị nta nke ndị ọrịa na-esonyere imi imi, imi imi, akpịrị akpịrị, myalgia na afọ ọsịsa.

Nka nka

Mpaghara ebumnuche	SARS-CoV-2 IgM/IgG mgbochi
Ọnọdụ nchekwa	4 ℃-30 ℃
Ụdị ihe atụ	Ọbara mmadụ, plasma, ọbara venous na ọbara mkpịsị aka
Ndụ nchekwa	Ọnwa iri abụọ na anọ
Ngwa inyeaka	Ọ dịghị mkpa
Ngwa ahịa ndị ọzọ	Ọ dịghị mkpa
Oge nchọpụta	10-15 nkeji
Nkọwapụta	Enweghị mmeghachi omume ọ bụla na nje nje, dị ka Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel influenza A (H1N1) influenza virus (2009) , seasonal H1N1 influenza virus, H3N2, H5N1, H7N9, influenza B virus Yamagata, Victoria, respiratory syncytial virus A na B, parainfluenza virus ụdị 1,2,3, Rhinovirus A, B, C, adenovirus ụdị 1,2,3, 4,5,7,55.